Related Articles
MHC class I down-regulation: tumour escape from immune surveillance? (Review)
Correlation between tumor microenvironment‑associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer
The expression of MHC class I, TAP1/2, and LMP2/7 gene in human gastric cancer cell lines.
CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens
Tumour MHC class I downregulation and immunotherapy (Review)